141 related articles for article (PubMed ID: 22398036)
1. Emergence of cytomegalovirus resistance to foscarnet in a patient receiving foscarnet salvage therapy for multidrug-resistant HIV infection.
Boutolleau D; Canestri A; Burrel S; Wirden M; Seang S; Clavel-Osorio C; Marcelin AG; Katlama C; Agut H
J Clin Virol; 2012 Jun; 54(2):194-6. PubMed ID: 22398036
[TBL] [Abstract][Full Text] [Related]
2. Emergence and persistence of multiple antiviral-resistant CMV strains in a highly immunocompromised child.
Iwasenko JM; Scott GM; Ziegler JB; Rawlinson WD
J Clin Virol; 2007 Oct; 40(2):152-5. PubMed ID: 17698411
[TBL] [Abstract][Full Text] [Related]
3. Emergence of multiple drug-resistant human cytomegalovirus variants in 2 patients with human immunodeficiency virus infection unresponsive to highly active antiretroviral therapy.
Baldanti F; Paolucci S; Parisi A; Meroni L; Gerna G
Clin Infect Dis; 2002 Apr; 34(8):1146-9. PubMed ID: 11915006
[TBL] [Abstract][Full Text] [Related]
4. A novel mutation in the UL54 gene of human cytomegalovirus isolates that confers resistance to foscarnet.
Ducancelle A; Champier G; Alain S; Petit F; Le Pors MJ; Mazeron MC
Antivir Ther; 2006; 11(4):537-40. PubMed ID: 16856628
[TBL] [Abstract][Full Text] [Related]
5. Resistant Cytomegalovirus Infection After Renal Transplantation: Literature Review.
Cintra-Cabrera M; Suárez-Benjumea A; Bernal-Blanco G; González-Roncero FM; Toapanta-Gaibor NG; Súñer-Poblet M; Pérez-Valdivia MÁ; Fernández-Cuenca F; Gentil-Govantes MÁ; Rocha-Castilla JL
Transplant Proc; 2018 Mar; 50(2):575-577. PubMed ID: 29579856
[TBL] [Abstract][Full Text] [Related]
6. [Cytomegalovirus sensitivity to anti-retroviral agents in patients infected with the human immunodeficiency virus with chorioretinitis in Spain].
Cañizares MA; Losada I; Pérez-Elías MJ; González J; Rubio R; Casado JL; Guerrero A
Enferm Infecc Microbiol Clin; 2001 Dec; 19(10):471-4. PubMed ID: 11844451
[TBL] [Abstract][Full Text] [Related]
7. Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis.
Weinberg A; Jabs DA; Chou S; Martin BK; Lurain NS; Forman MS; Crumpacker C; ;
J Infect Dis; 2003 Mar; 187(5):777-84. PubMed ID: 12599051
[TBL] [Abstract][Full Text] [Related]
8. Human cytomegalovirus resistance to antiviral drugs: diagnosis, monitoring and clinical impact.
Baldanti F; Gerna G
J Antimicrob Chemother; 2003 Sep; 52(3):324-30. PubMed ID: 12888590
[TBL] [Abstract][Full Text] [Related]
9. Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients.
Iwasenko JM; Scott GM; Naing Z; Glanville AR; Rawlinson WD
Transpl Infect Dis; 2011 Apr; 13(2):145-53. PubMed ID: 21070537
[TBL] [Abstract][Full Text] [Related]
10. Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients.
Myhre HA; Haug Dorenberg D; Kristiansen KI; Rollag H; Leivestad T; Asberg A; Hartmann A
Transplantation; 2011 Jul; 92(2):217-23. PubMed ID: 21685829
[TBL] [Abstract][Full Text] [Related]
11. How individual can personalized antiretroviral treatment be? Deep salvage in an HIV-1-infected patient.
Jensen B; Esser S; Kaiser R; Luebke N; Häussinger D
Intervirology; 2012; 55(2):167-71. PubMed ID: 22286888
[TBL] [Abstract][Full Text] [Related]
12. Is combination antiviral therapy for CMV superior to monotherapy?
Drew WL
J Clin Virol; 2006 Apr; 35(4):485-8. PubMed ID: 16387546
[TBL] [Abstract][Full Text] [Related]
13. Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation.
Shapira MY; Resnick IB; Chou S; Neumann AU; Lurain NS; Stamminger T; Caplan O; Saleh N; Efferth T; Marschall M; Wolf DG
Clin Infect Dis; 2008 May; 46(9):1455-7. PubMed ID: 18419454
[TBL] [Abstract][Full Text] [Related]
14. Foscarnet as salvage therapy in HIV-2-infected patient with antiretroviral treatment failure.
Stegmann S; Manea ME; Charpentier C; Damond F; Karmochkine M; Laureillard D; Si-Mohamed A; Weiss L; Piketty C
J Clin Virol; 2010 Jan; 47(1):79-81. PubMed ID: 19962343
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral salvage therapy for multiclass drug-resistant HIV-1-infected patients: from clinical trials to daily clinical practice.
Imaz A; Falcó V; Ribera E
AIDS Rev; 2011; 13(3):180-93. PubMed ID: 21799536
[TBL] [Abstract][Full Text] [Related]
16. Resistance to combined ganciclovir and foscarnet therapy in a liver transplant recipient with possible dual-strain cytomegalovirus coinfection.
Rodriguez J; Casper K; Smallwood G; Stieber A; Fasola C; Lehneman J; Heffron T
Liver Transpl; 2007 Oct; 13(10):1396-400. PubMed ID: 17902124
[TBL] [Abstract][Full Text] [Related]
17. Effect of foscarnet on quantities of cytomegalovirus and human immunodeficiency virus in blood of persons with AIDS.
Balfour HH; Fletcher CV; Erice A; Henry WK; Acosta EP; Smith SA; Holm MA; Boivin G; Shepp DH; Crumpacker CS; Eaton CA; Martin-Munley SS
Antimicrob Agents Chemother; 1996 Dec; 40(12):2721-6. PubMed ID: 9124829
[TBL] [Abstract][Full Text] [Related]
18. [In vitro susceptibility to ganciclovir and foscarnet of cytomegaloviruses].
Otegui M; Rabella N; Labeaga R; Herrero M; Margall R; Muñoz JM; Prats G
Rev Esp Quimioter; 2001 Jun; 14(2):155-64. PubMed ID: 11704769
[TBL] [Abstract][Full Text] [Related]
19. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
Reddy AJ; Zaas AK; Hanson KE; Palmer SM
J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480
[TBL] [Abstract][Full Text] [Related]
20. Potent and sustained antiviral response of raltegravir-based highly active antiretroviral therapy in HIV type 1-infected children and adolescents.
Briz V; León-Leal JA; Palladino C; Moreno-Perez D; de Ory SJ; De José MI; González-Tomé MI; Martín CG; Pocheville I; Ramos JT; Leal M; Muñoz-Fernández MÁ
Pediatr Infect Dis J; 2012 Mar; 31(3):273-7. PubMed ID: 22330165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
